Carol W. Greider — LLMpedia

Carol W. Greider
Christopher Michel · CC BY-SA 4.0 · source
Name	Carol W. Greider
Birth date	April 1, 1961
Birth place	San Diego, California, United States
Nationality	American
Fields	Molecular biology, Biochemistry, Genetics
Workplaces	Johns Hopkins University, Cold Spring Harbor Laboratory, University of California, Berkeley
Alma mater	University of California, Santa Barbara, University of California, Berkeley
Doctoral advisor	Elizabeth Blackburn
Known for	Discovery of telomerase
Awards	Nobel Prize in Physiology or Medicine (2009)

Contents

Carol W. Greider is an American molecular biologist best known for the discovery of telomerase and elucidation of telomere biology. Her work on chromosomal end protection influenced research in cancer, aging, genetics, molecular biology, and biochemistry, and earned major recognition across institutions such as Cold Spring Harbor Laboratory, Johns Hopkins University, and the National Academy of Sciences.

Early life and education

Greider was born in San Diego, California, and grew up during a period of expanding biomedical research in the United States, influenced by institutions including the Salk Institute for Biological Studies, the Scripps Institution of Oceanography, and the University of California, San Diego. She completed undergraduate studies at the University of California, Santa Barbara where she engaged with faculty linked to laboratories at Lawrence Berkeley National Laboratory and touchpoints with researchers from the National Institutes of Health and the Howard Hughes Medical Institute. For graduate training she entered the doctoral program at the University of California, Berkeley, joining the laboratory of Elizabeth Blackburn at the Joint Institute for Laboratory Astrophysics and collaborating with groups associated with the European Molecular Biology Laboratory and the Max Planck Society on nucleic acid biology.

Greider developed techniques to study terminal DNA structures using insights from protocols established at the Cold Spring Harbor Laboratory courses and methods pioneered at the Rosalind Franklin Institute and the Weizmann Institute of Science. In 1984 she and colleagues identified an activity that elongates telomeric DNA, later termed telomerase, building on concepts from work at the Carnegie Institution for Science and the Howard Hughes Medical Institute. Her experiments combined approaches from laboratories at the Salk Institute for Biological Studies and the Massachusetts Institute of Technology to demonstrate that telomerase contains an RNA component that serves as a template for telomere repeat synthesis, intersecting with findings from researchers at the Institute of Cancer Research and the European Bioinformatics Institute. Subsequent studies by Greider and collaborators connected telomerase action to telomere length regulation, chromosome stability, and cellular senescence, topics also investigated by teams at the Broad Institute, the Francis Crick Institute, and the Fred Hutchinson Cancer Center. Her contributions influenced translational research programs at the National Cancer Institute and therapeutic strategy development at biotechnology firms linked to Genentech, Amgen, and Biogen.

Greider held early research appointments and fellowships that engaged networks including the American Association for the Advancement of Science, the National Science Foundation, and the Gordon and Betty Moore Foundation. She served on the faculty of Johns Hopkins University and maintained a laboratory affiliated with Cold Spring Harbor Laboratory, interacting with principal investigators from the University of Cambridge, the University of Oxford, and the California Institute of Technology. Later appointments included roles at the University of California, Santa Cruz and visiting professorships involving partnerships with the Karolinska Institutet and the University of Tokyo. Throughout her career she participated in advisory boards for the National Institutes of Health, the Wellcome Trust, and the European Research Council, and collaborated with investigators from the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute on telomere-related projects.

Greider’s discoveries garnered recognition from organizations such as the Nobel Assembly at Karolinska Institutet, which awarded the Nobel Prize in Physiology or Medicine in 2009, and electing bodies including the National Academy of Sciences and the American Academy of Arts and Sciences. She received prizes from the Lasker Foundation, the Baltimore City Chamber of Commerce, the Royal Society, and the Japan Prize committees, and honors conferred by universities including Harvard University, Yale University, and the University of California. Professional societies such as the American Society for Cell Biology, the Society for Neuroscience, and the Biophysical Society recognized her contributions, and she obtained honorary degrees from institutions including the University of Cambridge and the Imperial College London.

Outside the laboratory Greider has been associated with advocacy and outreach initiatives connected to the March for Science, the Gordon Research Conferences, and STEM education programs at the Smithsonian Institution and the National Academy of Medicine. She has participated in public dialogues alongside figures from the World Health Organization, the Bill & Melinda Gates Foundation, and the National Science Foundation on issues intersecting biomedical research and public policy. Greider’s mentorship influenced trainees who later held positions at the Salk Institute for Biological Studies, the Cold Spring Harbor Laboratory, and leading universities, and she has contributed to discussions hosted by the American Association for Cancer Research and the Institute of Medicine.